Antipodes Partners’s Yum China YUMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-486,436
Closed -$30.8M 82
2023
Q1
$30.8M Sell
486,436
-58,886
-11% -$3.55M 1.07% 32
2022
Q4
$29.8M Sell
545,322
-445,890
-45% -$22.7M 1.07% 35
2022
Q3
$46.9M Sell
991,212
-300,264
-23% -$14.4M 1.88% 24
2022
Q2
$62.6M Buy
1,291,476
+157,754
+14% +$6.64M 2.61% 17
2022
Q1
$47.1M Buy
1,133,722
+32,324
+3% +$1.52M 1.67% 24
2021
Q4
$54.9M Buy
1,101,398
+213
+0% +$11.6K 1.97% 20
2021
Q3
$64M Sell
1,101,185
-1,330
-0.1% -$81.8K 2.19% 20
2021
Q2
$73M Buy
1,102,515
+291,055
+36% +$18.6M 2.63% 19
2021
Q1
$48M Sell
811,460
-777,635
-49% -$46.5M 1.95% 22
2020
Q4
$90.7M Sell
1,589,095
-722,940
-31% -$40.6M 3.94% 9
2020
Q3
$122M Sell
2,312,035
-406,355
-15% -$21.5M 5.61% 6
2020
Q2
$131M Buy
2,718,390
+233,504
+9% +$11M 5.92% 4
2020
Q1
$106M Sell
2,484,886
-103,193
-4% -$4.6M 5.54% 4
2019
Q4
$124M Buy
2,588,079
+18,554
+0.7% +$825K 5.6% 6
2019
Q3
$117M Sell
2,569,525
-240,183
-9% -$10.7M 5.57% 5
2019
Q2
$130M Buy
2,809,708
+2,386,169
+563% +$104M 5.96% 6
2019
Q1
$19M Buy
+423,539
New +$16.7M 0.94% 23

Other funds holding YUMC

Antipodes Partners's YUMC Position: Q2 2023 in Review

Antipodes Partners sold out of Yum China (YUMC) in Q2 2023, closing a stake of 486,436 shares — an estimated $30.8M sold.

Antipodes Partners first reported a position in YUMC in Q1 2019 and held it in 17 quarters. The position peaked at $131M in Q2 2020. 736 funds tracked by Wall St. Rank hold YUMC as of Q2 2023.

  • Antipodes Partners reported no remaining Yum China position as of Q2 2023 after selling out during the quarter.
  • Antipodes Partners sold 486,436 Yum China shares in Q2 2023, an estimated $30.8M.
  • Antipodes Partners first reported a position in Yum China in Q1 2019 and held it in 17 quarters.
  • Antipodes Partners's Yum China position peaked at $131M in Q2 2020.
  • 736 funds tracked by Wall St. Rank held Yum China as of Q2 2023.

Based on Antipodes Partners's 13F filing for Q2 2023, filed 25 Jul 2023.